hepatitis B virus infection involving a hematogenous reinfection of the liver and indicate that recruitment of liver cells to produce hepatitis B virus may occur in a pattern consistent with a replicative cycle of about 8 days.
The discovery of hepatitis B surface antigen (HB% Ag) (2, 6, 7) and hepatitis B core antigen (HBc Ag) (3) and the subsequent development of animal models for hepatitis B virus (HBV) infection (4, 16) have facilitated the study of this important disease of humans. Our current knowledge owes much to the development of sensitive radioimmunoassays for the measurement of these antigens and their corresponding antibodies in serum and to the application of immunofluorescence techiniques for their detection in tissues obtained during the course of infection. Nevertheless, the details of HBV production and pathogenesis remain to be elucidated.
Several investigators have applied immunofluorescence to the detection of HB8 Ag and/or HBc Ag in liver. Edgington and Ritt (10) clearly demonstrated the presence of (what is now known as) HB8 Ag in the cytoplasm of liver cells in a number of human patients. Others found hepatitis B-associated antigens in both the cytoplasm and the nuclei of hepatocytes (17, 18 
RESULTS
The courses of HBV infections in the two chimpanzees were basically similar. The salient features are displayed in Fig. 1 .
We first detected HB. antigenemia approximately 7 weeks after inoculation in both animals. From this point on, the parameters we followed became positive sooner in chimp 86 Support for the existence of such a biphasic disease is found in the data of Bradley et al. (8) , who observed two peaks of serum polymerase activity, one preceding or paralleling the development of antigenemia, the other following it. Our own data on chimp 87 (Fig. 2 ) support this: after three definitely positive serum specimens there was a period of 18 days during which six separate specimens were negative for HB. Ag. If one postulates nonspecific clearing mechanisms to account for loss of serum HB. Ag after its first appearance, then its second appearance can be seen as the expression of a secondary infection. The start of the second phase of antigenemia is 35 days after the start of the first phase, and this is close to the incubation period of 39 days for initial antigenemia. Focusing even more on the details of antigenemia shown in Fig. 2 , we note that the fluctuations occur with a periodicity of about 8 days. This could represent the time required for successive infections, each involving more cells and producing a larger total burst of virus particles. A replicative cycle of this length is certainly more commonly seen than is one of several weeks to several months. findings of others (8, 14) that deoxyribonucleic acid polymerase appears in the serum during or before early antigenemia. Unlike tests of serum, however, our examination of the liver by immunofluorescence reflects the number of cells containing a given antigen more than it does the amount of antigen produced. Moreover, since it involves tests of roughly equal sensitivity applied to the same tissue, it more probably gives a valid indication of the sequence in which the two antigens are synthesized. This sequence, as well as the persistence of cellular HB. Ag until or after the disappearance of cellular HB, Ag, is consistent with the postulated central role of the Dane particle in the synthesis of HB8 Ag coat material.
We have found, as others have (5), that histological and chemical evidence of liver damage is not detectable until long after the detection of HBV antigens in liver and the peak of HB. Ag in serum. The pathogenesis of hepatitis, therefore, may not be a function of virus production, although it probably depends on the presence of virus antigens within or on the cell. In particular, we see that the SGPT becomes normal only after HBV antigens are no longer detected in the liver. Rises in SGOT and SGPT bear various relationships to the appearance of HB. Ag and occur before, with, or after the detection of antibody (4, 11, 15, 19) . In general, however, the biochemical abnormalities occur at a time when anticomplementary activity in the sera is to be expected, and, in cases of hepatitis B, hepatitis A, and non-A-non-B hepatitis, anticomplementary activity has indeed been found to coincide with enzyme elevations (19) . All of this implicates humoral immune mechanisms in the pathogensis. There is also evidence that cellular immune responses play a role in hepatitis B. Irwin and co-workers (12) found that lymphocytes of patients with acute hepatitis B produce macrophage migration inhibitory factor when stimulated with purified HB. Ag. Moreover, in one case, followed through the course of illness, the production of migration inhibitory factor peaked as the SGOT began to rise and returned toward normal as the patient recovered (12) .
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